Ginkgo customers will now have access
to IdeeLab's local strain discovery capabilities, as well as
the ability to manufacture next-generation products in IdeeLab's
manufacturing facilities
PIRACICABA, Brazil, April 8,
2024 /PRNewswire/ -- IdeeLab Biotechnology, a
Brazilian company aiming to develop innovations and biological
solutions for agriculture, today announced that is has entered into
an agreement with Ginkgo Bioworks (NYSE: DNA), which is building
the leading platform for cell programming and biosecurity, to join
the Ginkgo Technology Network.
The Ginkgo Technology Network is a groundbreaking global
ecosystem of cutting-edge technology partners dedicated to driving
innovation in customer R&D programs. Ginkgo plans to integrate
the technological capabilities of its network partners to provide
customers with more robust end-to-end solutions to drive successful
R&D outcomes across biological end markets.
IdeeLab is leading sustainable agriculture biological products
development in Brazil
by developing new technologies on behalf of customers for the
crop input market. Particularly noteworthy, in Q1 2025, IdeeLab
will have the only plant in Brazil
certified by regulators to make ag input metabolites and proteins
from GMOs, which will enable next-generation products in
agriculture, such as metabolite and peptide/protein-based
biocontrol products that are potentially safer and more efficacious
versus conventional chemicals. The manufacturing facility will
eventually reach 6 million liters of fermentation capacity, which
is more than enough to enable clients to do commercial derisking
before potentially building out fermentation capacity of their
own.
IdeeLab's biotech platforms, pilot-scale facility and industrial
setting will complement Ginkgo's cell engineering and discovery
capabilities. With IdeeLab, customers can now work with Ginkgo in
various capacities such as metabolite and microbial discovery
through fermentation scale up, registration, field trialing, and
manufacturing a product in the fast-growing Brazilian biologicals
market.
Ginkgo will continue to add partners to the Technology Network
to further complement its offerings, and enable more clients in
Brazil to access and explore the
joint capabilities of the integrated Technology Network. Ginkgo is
already working with leading product developers in the Brazilian
market, and more are expected to join with this new expansion.
Ronaldo José Durigan Dalio, CEO of IdeeLab: "This
partnership with Ginkgo will help us leap into the future, and
leverages both companies to deliver even more innovative solutions
to the Brazilian market in a faster and more efficient way. IdeeLab
has been leading the development of the next generation of bio ag
input in Brazil, and connecting
GInkgo's expertise to ours in this process will also help us
explore new routes for improving both industrial production and
product field performance for our clients."
Anna Marie Wagner, Ginkgo's
SVP, Head of AI and Corporate Development: "IdeeLab has been
inspiring a new era in Brazilian agriculture and we're thrilled to
welcome them to the Ginkgo Technology Network! Adding IdeeLab to
our network now gives us the complete, end-to-end ability to
deliver ag biological products for customers, especially
next-generation products that are based on proteins, peptides and
metabolites."
About IdeeLab Biotechnology
IdeeLab is a fast-growing innovative ag biotechnology company in
Brazil, focused on developing
disruptive biological technologies and products for sustainable and
regenerative agriculture, including biocontrol of pests and
diseases, induction of plant resistance/tolerance
responses,biostimulation, nutritional cycling and modulation of
biotic/abiotic stress in major crops. Our multidisciplinary
approach enables us to address emerging needs of the global
agriculture market, providing biotechnology-as-a-service along
different stages of R&D, from Bioprospection and Discovery, to
Agronomical Validation and Go-to-Market (scale up, formulation,
shelf-life/quality control, technology transfer, and
manufacturing). Our expertise in phytopathology, plant physiology,
and biochemistry, and our laboratories and bioprocess facilities
are tailored to serve the development of ag inputs based on
microbial cell growth/spore titers, as well as metabolites,
peptides/proteins, interference RNA, CRISPR-edited, and
other GM-derived microorganisms. We are expanding these
capabilities to an industrial setting dedicated exclusively to B2B
production (white label), to be inaugurated at the end of 2024.
For more information, visit www.ideelab.com.br, or follow us
on social media channels Instagram
(@ideelab_biotech) and LinkedIn
(www.linkedin.com/company/ideelabbr/).
IDEELAB BIOTECHNOLOGY CONTACT:
contato@ideelab.com.br
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell
programming, providing flexible, end-to-end services that solve
challenges for organizations across diverse markets, from food and
agriculture to pharmaceuticals to industrial and specialty
chemicals. Ginkgo's biosecurity and public health unit, Concentric
by Ginkgo, is building global infrastructure for biosecurity to
empower governments, communities, and public health leaders to
prevent, detect and respond to a wide variety of biological
threats. For more information, visit ginkgobioworks.com
and concentricbyginkgo.com, read our blog, or follow us
on social media channels such as X (@Ginkgo and @ConcentricByGBW),
Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks)
or LinkedIn.
GINKGO BIOWORKS INVESTOR
CONTACT:
investors@ginkgobioworks.com
GINKGO BIOWORKS MEDIA
CONTACT:
press@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ideelab-joins-the-ginkgo-technology-network-to-provide-agriculture-companies-in-brazil-with-end-to-end-product-development--manufacturing-service-302109679.html
SOURCE IdeeLab Biotechnology